Thrombus aspiration (TA) has the potential for
reducing distal embolization and improving
microvascular perfusion. However, according to the
results from the latest trials, routine TA failed to
establish better clinical outcomes and was associated
with significantly increased risk of stroke. Hence
routine use of thrombus aspiration has been
downgraded to class III according to the latest
STEMI guidelines. Our aim was to study the impact
of selective use of thrombus aspiration guided by the
thrombus burden on both procedural and clinical
outcomes at 30 days,6 and 18 months of follow up.